In focus

Eli Lilly invests $3bn in injectable drug manufacturing facility

AI transforms route scouting for faster drug synthesis

Streamlining early phase drug development with continuous flow technologies

Clinical trials & development

More

Partner insightMore

Powered by Ingredients + Innovation

Solution for challenging antibodies – Planova™ S20N

Reliability, scale, and security of supply

Expand your knowledge

Industry Newsletters
Choose from regular, topic-based and special edition briefings
Resource centre
Discover cutting edge insight from our partners
Events & webinars
Explore our programme of live & on-demand content